ORLANDO, Fla., May 10, 2007 (PRIME NEWSWIRE) -- RedChip Companies, Inc. announced today that it has published a comprehensive company profile featuring detailed information on Viropro Inc. (OTCBB:VPRO). Viropro Inc. specializes in technology transfer for industrial production of affordable biological therapeutic products whose licenses have expired.
To view the Viropro Inc. company profile please visit: http://www.redchip.com/visibility/loadExternal.asp?extPage=files/clients/VPRO/VPROProfile.pdf.
Dr. Jean-Marie Dupuy, President and Chief Executive Officer of Viropro Inc., stated that, "The Viropro company profile is an important tool that RedChip is using to educate its extensive retail and institutional network about our story. We are certain that the RedChip company profile will bringer greater visibility to our stock."
Dave Gentry, CEO of RedChip Companies commented, "We are pleased to publish the Viropro company profile and provide the investment community with a more comprehensive level of information on this exciting company."
About Viropro Inc.
Viropro Inc. conducts operations through its subsidiary Viropro International Inc., whose Head Office is located in Montreal, Canada. Viropro is a rapidly expanding biopharmaceutical company specializing in the transfer of its technologies for industrial production of biogeneric therapeutic proteins, excluding therapeutic vaccines, for the treatment of various diseases including cancer, diabetes, hepatitis or multiple sclerosis. The company's principal objective is to bring about the transfer of technology to pharmaceutical companies in emerging markets with unmet medical needs such as in South America, Asia and Africa. To expand its range of expertise in biopharmaceuticals excluding therapeutic vaccines, Viropro has concluded strategic alliances with various scientific and business partners renowned in national and international spheres. Viropro's business model rests on a strategy aimed at generating recurrent short and long-term revenues, all while maximizing the value of assets and profits of its shareholders. For more information on Viropro Inc., please visit our website at www.viropro.com.
About RedChip Companies, Inc.
RedChip Companies is an international small-cap research and financial public relations firm with offices in Beijing and Orlando and affiliates in New York and San Diego. RedChip delivers measurable results for its clients through its extensive international market expertise as well as its comprehensive platform of products: RedChip Research(tm), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences held throughout the United States, and RedChip Radio(tm). To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/services.asp.
Viropro Inc. Safe Harbor Statement
Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. Any statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be "forward-looking statements". Forward-looking statements in this release may be identified through the use of such words as "expects", "anticipates", "estimates", "believes", or statements indicating certain actions "may", "could", or "might" occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company's ability to market its products and services in a competitive environment as well as other factors.